What is the dosage and treatment duration for Amoxy Clav (amoxicillin and clavulanic acid) 625?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate 625 mg Dosing and Duration

For adults with respiratory tract infections, amoxicillin-clavulanate 625 mg (500 mg amoxicillin/125 mg clavulanic acid) should be administered three times daily for 5-14 days depending on the specific infection type. 1

Standard Adult Dosing Regimens

The FDA-approved dosing for amoxicillin-clavulanate 625 mg varies by infection severity 1:

  • Mild to moderate infections: One 625 mg tablet every 8 hours 1
  • Respiratory tract infections and more severe infections: One 625 mg tablet every 8 hours, or alternatively 875/125 mg every 12 hours 1
  • Administration: May be taken without regard to meals, though absorption of clavulanate is enhanced when taken at the start of a meal 1

Duration by Infection Type

Acute Bacterial Rhinosinusitis

  • Standard duration: 5-7 days for uncomplicated cases 2
  • With risk factors (recent antibiotic use within 4-6 weeks, treatment failure, moderate disease): 625 mg three times daily for 5-7 days 3, 2
  • Note: Shorter 5-7 day courses are as effective as 10-day regimens in most cases 2

Chronic Rhinosinusitis

  • Standard duration: 14 days (or up to 3 weeks in comparative trials) 3
  • Dosing: 625 mg three times daily 3

Bronchiectasis Exacerbations

  • Duration: 14 days 2
  • Indication: Particularly for beta-lactamase producing Haemophilus influenzae 2

Community-Acquired Pneumonia (Pediatric Context)

  • Duration: 10 days for beta-lactam treatment of pneumococcal pneumonia 3
  • Pediatric dosing: 80 mg/kg/day of amoxicillin component in children below 5 years when indicated 3

Acute Bronchiolitis/Bronchitis (Pediatric)

  • Duration: 5-8 days when antibiotics are indicated 3
  • Note: First-line antibiotics generally not indicated unless high fever >38.5°C persisting >3 days 3

Key Clinical Considerations

Risk factors requiring amoxicillin-clavulanate over amoxicillin alone 3, 2:

  • Recent antibiotic use within past 4-6 weeks
  • Previous treatment failure
  • Moderate to severe disease
  • Age >65 years
  • Immunocompromised status
  • High local prevalence of resistant S. pneumoniae
  • Smokers or exposure to smoke
  • Comorbidities present

Common pitfall: Do not substitute two 250/125 mg tablets for one 500/125 mg tablet, as both contain the same amount of clavulanic acid (125 mg), which would result in clavulanate overdosing 1

Renal adjustment required 1:

  • GFR 10-30 mL/min: 625 mg every 12 hours
  • GFR <10 mL/min: 625 mg every 24 hours
  • Hemodialysis: 625 mg every 24 hours plus additional dose during and after dialysis

Tolerability

The most common adverse effect is diarrhea, which can be minimized by taking the medication at the start of meals 1, 4. The combination is generally well tolerated with gastrointestinal disturbances being mild in most cases 5, 4.

References

Guideline

Amoxicilina-Ácido Clavulánico Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.